help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clairmont, K. B.
Right arrow Articles by Czech, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clairmont, K. B.
Right arrow Articles by Czech, M. P.

Endocrinology, Vol 127, 1568-1573, Copyright © 1990 by Endocrine Society

ARTICLES

Insulin injection increases the levels of serum receptors for transferrin and insulin-like growth factor-II/mannose-6-phosphate in intact rats

KB Clairmont and MP Czech
Program in Molecular Medicine, University of Massachusetts Medical Center, Worcester 01655.

Previous work indicates that a serum form of the insulin-like growth factor-II/mannose-6-phosphate (IGF-II/Man-6-P) receptor that circulates in mammals is a truncated form of the cellular receptor which lacks its cytoplasmic domain. In this study the effects of insulin administration on the levels of the serum forms of IGF-II/Man-6-P and transferrin receptors were measured. After sc injection of insulin into rats fasted overnight, the amount of IGF-II/Man-6-P receptor in serum increases to approximately twice that observed in untreated animals within 30 min, then decreases to a level lower than the initial level by 60 min before returning to control values by 90 min. The time course of the initial increase in serum receptor levels in response to insulin is similar to that observed for the decrease in blood glucose concentrations. Measurements of serum enzyme activities (creatine kinase and lactate dehydrogenase) during this time show no significant increase in response to insulin treatment. Furthermore, the increase in serum IGF- II/Man-6-P receptors is proportional to the amount of insulin injected over the range tested. In diabetic rats the serum IGF-II/Man-6-P receptor concentration is decreased to approximately 80% as much serum receptor as that in normal age-matched rats. The acute response of serum IGF-II/Man-6-P receptor levels to insulin administration is similar in both time course and extent of change to the increase in isolated fat cells of cell surface receptor levels due to insulin action. These results suggest the hypothesis that insulin stimulates the movement of cellular IGF-II/Man-6-P receptors to the cell surface, where they are proteolytically cleaved and released into serum.


This article has been cited by other articles:


Home page
 Diabetes CareHome page
J. M. Fernandez-Real, J. M. Moreno, A. Lopez-Bermejo, B. Chico, J. Vendrell, and W. Ricart
Circulating Soluble Transferrin Receptor According to Glucose Tolerance Status and Insulin Sensitivity
Diabetes Care, March 1, 2007; 30(3): 604 - 608.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. A. Rutledge, I. Gaston, B. J. Root, T. E. McGraw, and C. A. Enns
The Transferrin Receptor Cytoplasmic Domain Determines Its Rate of Transport through the Biosynthetic Pathway and Its Susceptibility to Cleavage Early in the Pathway
J. Biol. Chem., May 15, 1998; 273(20): 12169 - 12175.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society